We are delighted to have advised NorthEdge on this multi-million-pound investment, which will help supercharge Antibody Analytics’ ambitious growth plans.
Matt Hodgson, Partner and Head of Claritas’ Manchester office commented: “NorthEdge have made a significant investment into an incredibly exciting business, which will provide Antibody Analytics with the capital and support they need to push on with their ambitious growth plans. Antibody Analytics are at the cutting edge of technology-led pre-clinical drug discovery, and NorthEdge’s investment represents not only an investment in this business, but a wider commitment to supporting UK-based, research-intensive businesses, aligning with one of the core pillars of the UK’s industrial strategy.
Liam and Simone at NorthEdge were a pleasure to work with and I’d like to thank the Claritas team of Alex Hall, Peter Hully, Adam Keates, Natalie Tran and Richard Smith for their hard work on this transaction.”
